UROsphere will take part in the European Association of Urology’s Annual Meeting and present scientific results on BPH research:
Gilles N, Lluel P, Rekik M, Guerard M, Palea S. AdTx1, a new peptidic α1-adrenoceptor antagonist with high affinity and selectivity for human α1A-adrenoceptor subtype: pharmacological characterization.
The company’s top managers will also present the company’s expertise to members of the Medicon Valley biotech cluster (in Sweden and Denmark) in March 2009.
To read the press release, click here .